These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30227748)

  • 1. The use of biologics and small molecules in pregnant patients with rheumatic diseases.
    Gerosa M; Argolini LM; Artusi C; Chighizola CB
    Expert Rev Clin Pharmacol; 2018 Oct; 11(10):987-998. PubMed ID: 30227748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of biologics in pregnant patients with rheumatic disease.
    Østensen M
    Expert Rev Clin Pharmacol; 2017 Jun; 10(6):661-669. PubMed ID: 28326845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety issues of biologics in pregnant patients with rheumatic diseases.
    Ostensen M
    Ann N Y Acad Sci; 2014 May; 1317():32-8. PubMed ID: 24840548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
    Götestam Skorpen C; Hoeltzenbein M; Tincani A; Fischer-Betz R; Elefant E; Chambers C; da Silva J; Nelson-Piercy C; Cetin I; Costedoat-Chalumeau N; Dolhain R; Förger F; Khamashta M; Ruiz-Irastorza G; Zink A; Vencovsky J; Cutolo M; Caeyers N; Zumbühl C; Østensen M
    Ann Rheum Dis; 2016 May; 75(5):795-810. PubMed ID: 26888948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation.
    Levy RA; de Jesús GR; de Jesús NR; Klumb EM
    Autoimmun Rev; 2016 Oct; 15(10):955-63. PubMed ID: 27490204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with biologics of pregnant patients with rheumatic diseases.
    Ostensen M; Förger F
    Curr Opin Rheumatol; 2011 May; 23(3):293-8. PubMed ID: 21346578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Bae SC
    Int J Rheum Dis; 2016 Nov; 19(11):1103-1111. PubMed ID: 26692536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease].
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R
    Med Clin (Barc); 2016 Oct; 147(8):352-360. PubMed ID: 27389618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are biological drugs safe in pregnancy?
    Calligaro A; Hoxha A; Ruffatti A; Punzi L
    Reumatismo; 2015 Mar; 66(4):304-17. PubMed ID: 25829190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis in pregnancy: a review (II).
    Ruiz V; Manubens E; Puig L
    Actas Dermosifiliogr; 2014 Nov; 105(9):813-21. PubMed ID: 24314892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapies and pregnancy: the story so far.
    Hyrich KL; Verstappen SM
    Rheumatology (Oxford); 2014 Aug; 53(8):1377-85. PubMed ID: 24352337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study.
    Bazzani C; Scrivo R; Andreoli L; Baldissera E; Biggioggero M; Canti V; Gerosa M; Pontikaki I; Ramoni V; Trespidi L; Zatti S; Caporali R; Gorla R; Iannone F; Lojacono A; Meroni P; Montecucco C; Motta M; Sabbadini MG; Valesini G; Tincani A
    Clin Exp Rheumatol; 2015; 33(5):688-93. PubMed ID: 26311348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.
    Flint J; Panchal S; Hurrell A; van de Venne M; Gayed M; Schreiber K; Arthanari S; Cunningham J; Flanders L; Moore L; Crossley A; Purushotham N; Desai A; Piper M; Nisar M; Khamashta M; Williams D; Gordon C; Giles I;
    Rheumatology (Oxford); 2016 Sep; 55(9):1693-7. PubMed ID: 26750124
    [No Abstract]   [Full Text] [Related]  

  • 14. Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
    Al-Mayouf SM; Alenazi A; AlJasser H
    Int J Rheum Dis; 2016 Jun; 19(6):600-5. PubMed ID: 24730661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reported congenital malformations after exposure to non-tumour necrosis factor inhibitor biologics: A retrospective comparative study in EudraVigilance.
    Ghalandari N; Crijns HJMJ; Bergman JEH; Dolhain RJEM; van Puijenbroek EP; Hazes JMW
    Br J Clin Pharmacol; 2022 Dec; 88(12):5378-5388. PubMed ID: 35894810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs.
    Østensen M; Lockshin M; Doria A; Valesini G; Meroni P; Gordon C; Brucato A; Tincani A
    Rheumatology (Oxford); 2008 Jun; 47 Suppl 3():iii28-31. PubMed ID: 18504282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases.
    N MS; Álvarez-Troncoso J; Robles-Marhuenda Á; De la Calle Fernández-Miranda M; Muner Hernando ML; Bartha JL
    J Autoimmun; 2024 Sep; 148():103301. PubMed ID: 39141986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review.
    Gisbert JP; Chaparro M
    Drugs; 2020 Jul; 80(11):1085-1100. PubMed ID: 32562207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence.
    Mouyis M; Flint JD; Giles IP
    Semin Arthritis Rheum; 2019 Apr; 48(5):911-920. PubMed ID: 30220537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy.
    Williams M; Chakravarty EF
    Curr Opin Rheumatol; 2014 May; 26(3):341-6. PubMed ID: 24663107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.